The Beachbody Company Earnings Calls
| Release date | May 12, 2026 |
| EPS estimate | -$0.0820 |
| EPS actual | $0.327 |
| EPS Surprise | 498.66% |
| Revenue estimate | 51.765M |
| Revenue actual | 54.284M |
| Revenue Surprise | 4.87% |
| Release date | Mar 10, 2026 |
| EPS estimate | $0.240 |
| EPS actual | $0.98 |
| EPS Surprise | 308.33% |
| Revenue estimate | 53.999M |
| Revenue actual | 55.536M |
| Revenue Surprise | 2.85% |
| Release date | Nov 10, 2025 |
| EPS estimate | -$0.540 |
| EPS actual | $0.510 |
| EPS Surprise | 194.44% |
| Revenue estimate | 54.224M |
| Revenue actual | 59.887M |
| Revenue Surprise | 10.44% |
| Release date | Aug 05, 2025 |
| EPS estimate | -$0.93 |
| EPS actual | -$0.570 |
| EPS Surprise | 38.71% |
| Revenue estimate | 55.15M |
| Revenue actual | 63.941M |
| Revenue Surprise | 15.94% |
Last 4 Quarters for The Beachbody Company
Below you can see how BODI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $3.82 |
| EPS estimate | -$0.93 |
| EPS actual | -$0.570 |
| EPS surprise | 38.71% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $4.55 |
| Jul 31, 2025 | $4.35 |
| Aug 01, 2025 | $3.91 |
| Aug 04, 2025 | $3.90 |
| Aug 05, 2025 | $3.82 |
| Aug 06, 2025 | $4.51 |
| Aug 07, 2025 | $4.35 |
| Aug 08, 2025 | $4.61 |
| Aug 11, 2025 | $4.55 |
| 4 days before | -16.04% |
| 4 days after | 19.11% |
| On release day | 18.06% |
| Change in period | 0% |
| Release date | Nov 10, 2025 |
| Price on release | $5.02 |
| EPS estimate | -$0.540 |
| EPS actual | $0.510 |
| EPS surprise | 194.44% |
| Date | Price |
|---|---|
| Nov 04, 2025 | $4.60 |
| Nov 05, 2025 | $4.33 |
| Nov 06, 2025 | $4.25 |
| Nov 07, 2025 | $5.00 |
| Nov 10, 2025 | $5.02 |
| Nov 11, 2025 | $5.92 |
| Nov 12, 2025 | $5.89 |
| Nov 13, 2025 | $6.11 |
| Nov 14, 2025 | $6.27 |
| 4 days before | 9.13% |
| 4 days after | 24.90% |
| On release day | 17.93% |
| Change in period | 36.30% |
| Release date | Mar 10, 2026 |
| Price on release | $8.33 |
| EPS estimate | $0.240 |
| EPS actual | $0.98 |
| EPS surprise | 308.33% |
| Date | Price |
|---|---|
| Mar 04, 2026 | $8.34 |
| Mar 05, 2026 | $8.70 |
| Mar 06, 2026 | $8.42 |
| Mar 09, 2026 | $8.20 |
| Mar 10, 2026 | $8.33 |
| Mar 11, 2026 | $10.91 |
| Mar 12, 2026 | $10.74 |
| Mar 13, 2026 | $10.56 |
| Mar 16, 2026 | $11.16 |
| 4 days before | -0.0600% |
| 4 days after | 33.97% |
| On release day | 30.97% |
| Change in period | 33.89% |
| Release date | May 12, 2026 |
| Price on release | $12.95 |
| EPS estimate | -$0.0820 |
| EPS actual | $0.327 |
| EPS surprise | 498.66% |
| Date | Price |
|---|---|
| May 06, 2026 | $13.91 |
| May 07, 2026 | $14.07 |
| May 08, 2026 | $13.61 |
| May 11, 2026 | $12.58 |
| May 12, 2026 | $12.95 |
| May 13, 2026 | $12.61 |
| May 14, 2026 | $12.64 |
| May 15, 2026 | $11.31 |
| May 18, 2026 | $10.17 |
| 4 days before | -6.90% |
| 4 days after | -21.47% |
| On release day | -2.63% |
| Change in period | -26.89% |
The Beachbody Company Earnings Call Transcript Summary of Q1 2026
Key points for investors: 1) Strong profitability momentum: Q1 2026 revenue was $54.3M (above guidance). The company reported its third consecutive quarter of net income ($2.3M), third consecutive quarter of operating income ($3.1M), and its 10th consecutive quarter of positive adjusted EBITDA ($8.0M). Gross margin remained healthy at 71.8%. 2) Improved financial flexibility and operating leverage: cash of $36.6M vs. ~$25M debt principal; management highlights a materially reduced EBITDA breakeven (from >$900M in 2022 to ~ $180M today). 3) Strategic pivot to nutrition + omnichannel retail: management is prioritizing nutrition (much larger TAM vs. digital fitness) and pursuing DTC, ecommerce (Shopify), distributor networks and retail placement. Recent retail/distribution wins include Sprouts (~80 stores), Kahi (access to ~30,000 grocers via distributor network), and a planned chain-wide Shakeology listing at Vitamin Shoppe (~640+ stores) later this year. 4) Product & go-to-market progress: P90X Generation Next launched (new P90X supplement SKUs and RTD energy drinks) and the 10-Minute Body micro-workout line continues to scale; Shopify migration is improving conversion and checkout experience. 5) Near-term revenue dynamics and cadence: revenue is still impacted by the unwind of legacy MLM remnant revenue; management expects Q3 2026 to be the first quarter providing a clean year-over-year comparison of the new business model. Q2 2026 guidance: revenues $46M–$51M, net income (loss) between ($3M) and breakeven, adjusted EBITDA $3M–$6M; mix approx. 60% digital / 40% nutrition & other for Q2. 6) Margins & unit economics: digital gross margin targeted ~86%–88%; nutrition gross margin targeted ~43%–47% (management expects wholesale nutrition to sit in the mid-40s as retail scales), and management is focused on growing gross profit dollars as nutrition volume increases. 7) Risks / timeline: execution risk around retailer planogram cycles (6–12 month timelines), retail rollout timing (some tests this summer; broader national placements spring 2027), early-stage retail execution and inventory/promotional impacts (Q1 nutrition margin decline included inventory adjustments). Management reiterates this is an early-stage omnichannel transformation where material retail yield is expected to ramp in H2 2026 and more meaningfully in 2027 and beyond.
Sign In
Buy BODI